New York Pradaxa Lawsuit Attorney
In 2014, German drug manufacturer Boehringer Ingelheim agreed to pay out a $650 million settlement to 4,000 families who had been adversely affected by their anticoagulant drug, Pradaxa.
The settlement came after thousands of patients, doctors, and medical professionals reported that the relatively new blood thinner was causing life-threatening bleeding in some patients that could not be stopped via traditional treatments. During the case, defective drug attorneys argued that the pharmaceutical company misled consumers in their marketing messages by stating that their drug was a better and safer alternative to the older blood thinner, warfarin.
Among the evidence in the case was a documentation that Boehringer Ingelheim tried to revise or even destroy proof that Pradaxa patients’ blood should be monitored.
Even though the above class action lawsuit is settled, victims of Pradaxa and their families can still act. Speak to a knowledgeable, experienced New York City Pradaxa lawyer at Meirowitz and Wasserberg today to learn more about your case and your legal options.
Pradaxa Fast Facts
Generic name: Dabigatran
Uses: Blood thinner (anticoagulant)
Treatments for: stroke prevention for atrial fibrillation, deep vein thrombosis and pulmonary embolism prevention, especially in those recovering from hip or knee replacement surgery.
Possible side effects: gastrointestinal issues, stomach bleeding, intestinal bleeding, intracranial bleeding, heart attacks.
FDA Approval: 2010
Manufacturer: Boehringer Ingelheim
Antidote: Idarucizumab, approved in 2015
Pradaxa Dangers, Compared to Warfarin
Pradaxa, also known by its generic name, Dabigatran, is part of a new generation of blood thinners that were marketed as a significant improvement over the traditionally used warfarin. Approved by the Food & Drug Administration in 2010, Boehringer Ingelheim claimed that the drug could be usage at the same dosage with all patients and that patients did not need to have their diet or blood monitored while they took the medication.
Boehringer Ingelheim did not stress the drug’s side effects, which include stomach and brain bleeding, or the fact that the drug did not have an antidote like warfarin did.
The Institute for Safe Medication Practices reported that by 2014, the drug had caused 1,000 deaths among the 850,000 people who took it.
Although an antidote, Idarucizumab, was approved for use in 2015, doctors and patients continue to be misled by the company concerning the drug’s advantages and the drug’s serious and sometimes deadly side effects.
Experienced Defective Drug Attorneys | Meirowitz & Wasserberg
Suffering from the adverse effects of a prescription drug can be more than painful and injurious, it can also be stressful, overwhelming, angering, and confusing. It can be difficult to act, especially if you aren’t sure what happened during your medical treatment or who is to blame with your injuries.
A huge number of defective drug cases go unreported each year for just these reasons. If you believe that your internal bleeding may have been caused by unmonitored Pradaxa use, speak to a pradaxa attorney today about your case. We can help you examine the evidence in your case, find a medical expert to analyze your medical records, and determine your best options for legal action. We can also tell you if you likely do not have a valid defective drug lawsuit.
We offer free, no-obligation consultations. To learn more, please contact our offices by calling 212-897-1988 or filling out our short contact form. Get the information you need – and peace of mind – today.